Home/Pipeline/Vasonatrite (naftidrofuryl)

Vasonatrite (naftidrofuryl)

Peripheral arterial disease

ApprovedActive

Key Facts

Indication
Peripheral arterial disease
Phase
Approved
Status
Active
Company

About OM Pharma

OM Pharma is a long-established Swiss biopharmaceutical company with a specialized focus on bacterial immunotherapies for infection prevention and vascular diseases. Its core business model revolves around developing and commercializing immunomodulatory products, primarily derived from bacterial lysates, to train the immune system. The company has a global commercial footprint with a portfolio of approved products, positioning it in the 'Commercial' stage. As a private company, it leverages decades of experience in microbial-based therapeutics.

View full company profile

Other Peripheral arterial disease Drugs

DrugCompanyPhase
ADSC Therapy for Critical Limb IschemiaA4CellPre-clinical